Zobrazeno 1 - 10
of 103
pro vyhledávání: '"D. D. Belin"'
Autor:
Larry D. Schertz, Eric A. Mintz, P. A. Horine, Carol M. Fendrick, Tobin J. Marks, D. D. Belin, Thomas E. Bitterwolf, J. A. Sheldon, T. L. Hubler
Publikováno v:
Inorganic Syntheses
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ddc8034c7970cd1e439daa0a60ece20
https://doi.org/10.1002/9780470132609.ch47
https://doi.org/10.1002/9780470132609.ch47
Autor:
Daniel ML; Department of Psychology, University of Cambridge, Downing Street, Cambridge, CB2 3EB, UK., Cocker PJ; Department of Psychology, University of Cambridge, Downing Street, Cambridge, CB2 3EB, UK., Lacoste J; Service de Psychiatrie et Addictologie, CHU de Martinique, Fort de France Cedex, France., Mar AC; Department of Neuroscience and Physiology, Neuroscience Institute, New York University School of Medicine, New York, NY, USA., Houeto JL; Service de Neurologie, CIC-INSERM 1402, CHU de Poitiers, Poitiers Cedex, France., Belin-Rauscent A; Department of Psychology, University of Cambridge, Downing Street, Cambridge, CB2 3EB, UK., Belin D; Department of Psychology, University of Cambridge, Downing Street, Cambridge, CB2 3EB, UK.
Publikováno v:
The European journal of neuroscience [Eur J Neurosci] 2017 Nov; Vol. 46 (10), pp. 2620-2628. Date of Electronic Publication: 2017 Oct 06.
Autor:
Belin D; FENS-Kavli Network of Excellence, Europe-wide.; Department of Pharmacology, University of Cambridge, Cambridge, UK., Rolls A; FENS-Kavli Network of Excellence, Europe-wide.; Technion- Israel Institute of Technology, Haifa, Israel.
Publikováno v:
The European journal of neuroscience [Eur J Neurosci] 2016 May; Vol. 43 (9), pp. 1123-7. Date of Electronic Publication: 2016 Mar 31.
Autor:
Belin-Rauscent A; Department of Pharmacology, University of Cambridge, Cambridge, UK.; Behavioral and Clinical Neuroscience Institute, University of Cambridge, Cambridge, UK., Daniel ML; Inserm CIC-1402, Université de Poitiers, Poitiers, France., Puaud M; Department of Pharmacology, University of Cambridge, Cambridge, UK.; Behavioral and Clinical Neuroscience Institute, University of Cambridge, Cambridge, UK., Jupp B; Behavioral and Clinical Neuroscience Institute, University of Cambridge, Cambridge, UK.; Department of Psychology, University of Cambridge, Cambridge, UK., Sawiak S; Behavioral and Clinical Neuroscience Institute, University of Cambridge, Cambridge, UK., Howett D; Department of Pharmacology, University of Cambridge, Cambridge, UK., McKenzie C; Department of Pharmacology, University of Cambridge, Cambridge, UK., Caprioli D; Behavioral Neuroscience Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD, USA., Besson M; Neurobiologie Intégrative des Systèmes Cholinergiques, Institut Pasteur, Paris, France., Robbins TW; Behavioral and Clinical Neuroscience Institute, University of Cambridge, Cambridge, UK.; Department of Psychology, University of Cambridge, Cambridge, UK., Everitt BJ; Behavioral and Clinical Neuroscience Institute, University of Cambridge, Cambridge, UK.; Department of Psychology, University of Cambridge, Cambridge, UK., Dalley JW; Behavioral and Clinical Neuroscience Institute, University of Cambridge, Cambridge, UK.; Department of Psychology, University of Cambridge, Cambridge, UK.; Department of Psychiatry, University of Cambridge, Cambridge, UK., Belin D; Department of Pharmacology, University of Cambridge, Cambridge, UK.; Behavioral and Clinical Neuroscience Institute, University of Cambridge, Cambridge, UK.
Publikováno v:
Molecular psychiatry [Mol Psychiatry] 2016 Apr; Vol. 21 (4), pp. 445.
Autor:
Belin-Rauscent A; Department of Pharmacology, University of Cambridge, Cambridge, UK.; Behavioral and Clinical Neuroscience Institute, University of Cambridge, Cambridge, UK., Daniel ML; Inserm CIC-1402, Université de Poitiers, Poitiers, France., Puaud M; Department of Pharmacology, University of Cambridge, Cambridge, UK.; Behavioral and Clinical Neuroscience Institute, University of Cambridge, Cambridge, UK., Jupp B; Behavioral and Clinical Neuroscience Institute, University of Cambridge, Cambridge, UK.; Department of Psychology, University of Cambridge, Cambridge, UK., Sawiak S; Behavioral and Clinical Neuroscience Institute, University of Cambridge, Cambridge, UK., Howett D; Department of Pharmacology, University of Cambridge, Cambridge, UK., McKenzie C; Department of Pharmacology, University of Cambridge, Cambridge, UK., Caprioli D; Behavioral Neuroscience Branch, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD, USA., Besson M; Neurobiologie Intégrative des Systèmes Cholinergiques, Institut Pasteur, Paris, France., Robbins TW; Behavioral and Clinical Neuroscience Institute, University of Cambridge, Cambridge, UK.; Department of Psychology, University of Cambridge, Cambridge, UK., Everitt BJ; Behavioral and Clinical Neuroscience Institute, University of Cambridge, Cambridge, UK.; Department of Psychology, University of Cambridge, Cambridge, UK., Dalley JW; Behavioral and Clinical Neuroscience Institute, University of Cambridge, Cambridge, UK.; Department of Psychology, University of Cambridge, Cambridge, UK.; Department of Psychiatry, University of Cambridge, Cambridge, UK., Belin D; Department of Pharmacology, University of Cambridge, Cambridge, UK.; Behavioral and Clinical Neuroscience Institute, University of Cambridge, Cambridge, UK.
Publikováno v:
Molecular psychiatry [Mol Psychiatry] 2016 Apr; Vol. 21 (4), pp. 491-9. Date of Electronic Publication: 2015 Sep 15.
Autor:
Belin D; Department of Pharmacology, University of Cambridge, Cambridge, UK.; Behavioural and Clinical Neuroscience Institute, University of Cambridge., Belin-Rauscent A; Department of Pharmacology, University of Cambridge, Cambridge, UK.; Behavioural and Clinical Neuroscience Institute, University of Cambridge., Everitt BJ; Behavioural and Clinical Neuroscience Institute, University of Cambridge.; Department of Psychology, University of Cambridge, Cambridge, UK., Dalley JW; Behavioural and Clinical Neuroscience Institute, University of Cambridge.; Department of Psychology, University of Cambridge, Cambridge, UK.; Department of Psychiatry, University of Cambridge, Cambridge, UK.
Publikováno v:
Genes, brain, and behavior [Genes Brain Behav] 2016 Jan; Vol. 15 (1), pp. 74-88. Date of Electronic Publication: 2015 Nov 13.
Autor:
Belin D; CRI U862, INSERM, 146 rue Léo Saignat, 33077 Bordeaux Cedex, France., Deroche-Gamonet V, Jaber M
Publikováno v:
Psychopharmacology [Psychopharmacology (Berl)] 2007 Sep; Vol. 193 (4), pp. 567-78. Date of Electronic Publication: 2007 May 17.
Autor:
Belin D; Département de Pathologie, Université de Genève, CH-1211 Geneva, Switzerland. dominique.belin@medecine.unige.ch, Guzman LM, Bost S, Konakova M, Silva F, Beckwith J
Publikováno v:
Journal of molecular biology [J Mol Biol] 2004 Jan 09; Vol. 335 (2), pp. 437-53.
Autor:
Prella M; Division of Haematology, Department of Medicine, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland., Baccalà R, Horisberger JD, Belin D, Di Raimondo F, Invernizzi R, Garozzo R, Schapira M
Publikováno v:
British journal of haematology [Br J Haematol] 2001 Jul; Vol. 114 (1), pp. 230-2.
Autor:
Fischer-Lougheed J; Département de Physiologie et, Centre Médical Universitaire, CH-1211 Geneva 4, Switzerland., Liu JH, Espinos E, Mordasini D, Bader CR, Belin D, Bernheim L
Publikováno v:
The Journal of cell biology [J Cell Biol] 2001 May 14; Vol. 153 (4), pp. 677-86.